Search for the latest oncology news by tumour type
Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in premenopausal as well as postmenopausal women
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women…